SCHEMBL29495956

SCHEMBL29495956

CN(N=C(c1ccccc1)c1ccccc1)c1ccc2ccccc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.45
▸ HPGD P15428 2/20 0.45
▸ GFER P55789 1/20 0.45
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ RAB9A P51151 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ HTT P42858 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CTSL P07711 1/20 0.38
▸ CTSK P43235 1/20 0.38
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ ACHE P22303 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29495959 1.00 ALDH1A1 (0.45) ALDH1A1HPGDGFERMEN1KMT2A
SCHEMBL11699938 0.80 ALDH1A1 (0.50) ALDH1A1HPGDGFERMEN1KMT2A
SCHEMBL3820980 0.76 ALDH1A1 (0.47) ALDH1A1HPGDGFERMEN1KMT2A
SCHEMBL31419288 0.72 ALDH1A1 (0.44) ALDH1A1HPGDGFERMEN1KMT2A
SCHEMBL8509189 0.70 HTT (0.46) ALDH1A1RAB9ANPC1HTTNPSR1
SCHEMBL29495799 0.70 SIGMAR1 (0.50) ALDH1A1HPGDGFERL3MBTL1CTSL
SCHEMBL10498731 0.69 ALDH1A1 (0.50) ALDH1A1HPGDGFERMEN1KMT2A
SCHEMBL372242 0.69 TERT (0.54) ALDH1A1RAB9ANPC1HTTNPSR1
SCHEMBL29463702 0.69 TERT (0.54) ALDH1A1RAB9ANPC1HTTNPSR1
SCHEMBL5441435 0.69 HTT (0.49) ALDH1A1RAB9ANPC1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022072975-A1 COMPOSITIONS AND METHODS OF TREATMENT FOR SARS-COV-2 THROUGH PAPAIN PROTEASE INHIBITION UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2022-04-07 — — WO disclosed
Send feedback